1h Free Analyst Time
The blood glucose monitoring devices market is forecasted to grow by USD 10.14 billion during 2024-2029, accelerating at a CAGR of 10% during the forecast period. The report on the blood glucose monitoring devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global burden of diabetes, technological advances in blood glucose monitoring devices, and availability of reimbursement for blood glucose monitoring devices.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The blood glucose monitoring devices market is segmented as below:
By End-user
- Hospitals
- Home care
- Diagnostic centers
By Product
- SMBG
- CGM
- Lancets
By Indication
- Type-2 diabetes population
- Type-1 diabetes population
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the blood glucose monitoring devices market covers the following areas:
- Blood Glucose Monitoring Devices Market sizing
- Blood Glucose Monitoring Devices Market forecast
- Blood Glucose Monitoring Devices Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by End-user
9 Market Segmentation by Product
10 Market Segmentation by Indication
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity/Restraints
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global blood glucose monitoring devices market: Abbott Laboratories, ACON Laboratories Inc., Agamatrix Inc., ARKRAY Inc., Ascensia Diabetes Care Holdings AG, Atlas Medical GmbH, Dexcom Inc., F. Hoffmann La Roche Ltd., LifeScan IP Holdings LLC, medisana GmbH, Medtronic Plc, Murata Manufacturing Co. Ltd., Nipro Corp., Ok Biotech Co Ltd., Prodigy Diabetes Care LLC, Rossmax International Ltd., TaiDoc Technology Corp., Tandem Diabetes Care Inc., Trivida Health Inc., and Ypsomed Holding AG.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is smart watch-based apps."
According to the report, one of the major drivers for this market is the rising global burden of diabetes.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- ACON Laboratories Inc.
- Agamatrix Inc.
- ARKRAY Inc.
- Ascensia Diabetes Care Holdings AG
- Atlas Medical GmbH
- Dexcom Inc.
- F. Hoffmann La Roche Ltd.
- LifeScan IP Holdings LLC
- medisana GmbH
- Medtronic Plc
- Murata Manufacturing Co. Ltd.
- Nipro Corp.
- Ok Biotech Co Ltd.
- Prodigy Diabetes Care LLC
- Rossmax International Ltd.
- TaiDoc Technology Corp.
- Tandem Diabetes Care Inc.
- Trivida Health Inc.
- Ypsomed Holding AG
